A Prospective Study of Endoscopic Ultrasound-guided Celiac (CB) Effectiveness

Indiana University1 site in 1 country127 target enrollmentJune 2002

ConditionsChronic Pancreatitis Pancreatic Cancer

Interventions98% dehydrated alcohol triamcinolone

Drugstriamcinolone 98% dehydrated alcohol

Overview

Phase: Not Applicable
Intervention: 98% dehydrated alcohol
Conditions: Chronic Pancreatitis
Sponsor: Indiana University
Enrollment: 127
Locations: 1
Status: Completed
Last Updated: 11 years ago

Overview Investigators Eligibility Criteria Arms & Interventions Outcomes Sites Similar Trials

Overview

Brief Summary

The purpose of this prospective study is to measure the clinical effectiveness of EUS-guided CB in subjects, 50 who have chronic pancreatitis and 50 who have pancreatic cancer, that are already undergoing celiac block for clinical reasons.

Registry

clinicaltrials.gov

Start Date

June 2002

End Date

December 2012

Last Updated

11 years ago

Study Type

Observational

Sex

All

Investigators

Sponsor

Indiana University

Responsible Party

Sponsor

Eligibility Criteria

Inclusion Criteria

•Patients with chronic abdominal pain from documented chronic pancreatitis or pancreatic cancer or other visceral malignancy that are undergoing EUS-guided CB (for purposes other than this study) will be eligible to participate in this study.
•Patients with chronic pancreatitis and pancreatic cancer must have documented disease by CT, ERCP, or EUS.
•No evidence of dementia or altered mental status that would prohibit the giving and understanding of informed consent, and no evidence of psychiatric risk that would preclude adequate compliance with this protocol.
•Patient must provide signed written informed consent